Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.
暂无分享,去创建一个
J. Berzofsky | W. Bishai | S. Kaufmann | U. Schaible | M. Lutz | S. Khader | G. Walzl | D. Gabrilovich | R. Hafner | S. Ostrand-Rosenberg | Y. Sui | A. Dorhoi | A. Garg | N. du Plessis | R. Mahon | Leigh A. Kotze | Nelita du Plessis
[1] M. Lutz,et al. Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells , 2019, Front. Immunol..
[2] M. Zimmerman,et al. Fatty acid oxidation impairs macrophage effector functions that control Mycobacterium tuberculosis , 2019, bioRxiv.
[3] H. Gideon,et al. Neutrophils express pro- and anti-inflammatory cytokines in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques , 2019, Mucosal Immunology.
[4] Changqing Li,et al. LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression , 2019, Cancer management and research.
[5] Denis Routkevitch,et al. Targeting Myeloid Cells in Combination Treatments for Glioma and Other Tumors , 2019, Front. Immunol..
[6] Y. Zhang,et al. Lnc-C/EBPβ Modulates Differentiation of MDSCs Through Downregulating IL4i1 With C/EBPβ LIP and WDR5 , 2019, Front. Immunol..
[7] M. Lutz,et al. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability. , 2019, JCI insight.
[8] K. Flaherty,et al. Potential role of myeloid-derived suppressor cells in pulmonary fibrosis , 2019, The Journal of Immunology.
[9] S. Spector,et al. Myeloid derived suppressor cells (MDSC) from HIV-infected individuals are defective in innate immunity to Mycobacterium tuberculosis thus increasing the risk of tuberculosis , 2019, The Journal of Immunology.
[10] M. Bobiński,et al. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer , 2019, Front. Immunol..
[11] N. Hockstein,et al. Fatty acid transporter 2 reprograms neutrophils in cancer , 2019, Nature.
[12] A. Prince,et al. Interleukin-10 Produced by Myeloid-Derived Suppressor Cells Provides Protection to Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 by Enhancing Its Clearance in the Airways , 2019, Infection and Immunity.
[13] J. Berzofsky,et al. Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response , 2019, The Journal of clinical investigation.
[14] W. Bishai,et al. Pharmacologic Exhaustion of Suppressor Cells with Tasquinimod Enhances Bacterial Clearance during Tuberculosis , 2019, American journal of respiratory and critical care medicine.
[15] S. H. van der Burg,et al. Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy , 2019, Journal of Immunotherapy for Cancer.
[16] J. Chen,et al. Gemcitabine nanoparticles promote antitumor immunity against melanoma. , 2019, Biomaterials.
[17] Yadan Wang,et al. Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis , 2018, BMC Cancer.
[18] J. Utikal,et al. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression , 2018, British Journal of Cancer.
[19] K. Tenbrock,et al. Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression , 2018, Front. Immunol..
[20] S. Kaufmann,et al. Human Monocytic Suppressive Cells Promote Replication of Mycobacterium tuberculosis and Alter Stability of in vitro Generated Granulomas , 2018, Front. Immunol..
[21] L. Joosten,et al. Non-specific effects of vaccines: Current evidence and potential implications. , 2018, Seminars in immunology.
[22] G. Walzl,et al. Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis , 2018, Front. Cell. Infect. Microbiol..
[23] Michael Y. Gerner,et al. Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination. , 2018, Cell host & microbe.
[24] W. Jacobs,et al. Decision letter: Mycobacterium tuberculosis induces decelerated bioenergetic metabolism in human macrophages , 2018 .
[25] M. Wicha,et al. Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. , 2018, Cell metabolism.
[26] B. Hadaschik,et al. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets , 2018, Clinical Cancer Research.
[27] D. Russell,et al. Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny , 2018, The Journal of experimental medicine.
[28] B. Arteta,et al. CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver. , 2018, Oncology reports.
[29] J. Utikal,et al. Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression , 2018, Front. Immunol..
[30] J. Mazières,et al. Baseline circulating myeloid-derived suppressor cells and response to PD-1 inhibitor in non-small cell lung cancer patients. , 2018 .
[31] D. Gabrilovich,et al. Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.
[32] C. Fenselau,et al. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment , 2018, The Journal of Immunology.
[33] A. Dorhoi,et al. Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections , 2018, Front. Immunol..
[34] E. Jensen,et al. Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation , 2017, Nature Medicine.
[35] A. Beineke,et al. Identification of a Novel Subset of Myeloid-Derived Suppressor Cells During Chronic Staphylococcal Infection That Resembles Immature Eosinophils , 2017, The Journal of infectious diseases.
[36] U. Schaible,et al. Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity , 2017, Front. Immunol..
[37] T. Rossouw,et al. The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders , 2017, Front. Immunol..
[38] Maxim N. Artyomov,et al. Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis. , 2017, JCI insight.
[39] Sijia He,et al. Myeloid-Derived Suppressor Cells Associated With Disease Progression in Primary HIV Infection: PD-L1 Blockade Attenuates Inhibition , 2017, Journal of acquired immune deficiency syndromes.
[40] B. Ryffel,et al. Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity via TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy , 2017, Front. Immunol..
[41] W. Bishai,et al. Suppressor Cell–Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis , 2017, The Journal of infectious diseases.
[42] James A. Hutchinson,et al. Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function. , 2017, Blood advances.
[43] L. Miller,et al. Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy , 2017, Journal of Immunotherapy for Cancer.
[44] W. Janssen,et al. Three Unique Interstitial Macrophages in the Murine Lung at Steady State , 2017, American journal of respiratory cell and molecular biology.
[45] Christopher J. Miller,et al. Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques , 2017, PLoS pathogens.
[46] W. Chen,et al. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis , 2017, Cell Death & Disease.
[47] A. Cheng,et al. Delineating the epigenetic regulation of myeloid derived suppressor cell generation in hepatocellular carcinoma associated with cirrhosis , 2017, The Journal of Immunology.
[48] S. Spector,et al. HIV myeloid derived suppressor cells (MDSC) are defective in innate immunity to Mycobacterium bovis BCG , 2017, The Journal of Immunology.
[49] C. Agrati,et al. Granulocytic Myeloid–Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level , 2017, Journal of acquired immune deficiency syndromes.
[50] P. Lu,et al. Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery , 2017, mBio.
[51] J. Berzofsky,et al. Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy , 2017, Oncoimmunology.
[52] S. Spector,et al. Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4 , 2017, Scientific Reports.
[53] A. Kritski,et al. Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice , 2017, PloS one.
[54] A. Al-Khami,et al. Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity , 2017, Front. Immunol..
[55] Hiroyuki Yamada,et al. Neutrophils and the S100A9 protein critically regulate granuloma formation. , 2016, Blood advances.
[56] R. Hafner,et al. Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination , 2016, Front. Immunol..
[57] George A. Dominguez,et al. Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody , 2016, Clinical Cancer Research.
[58] S. Kaufmann,et al. Novel approaches to tuberculosis vaccine development. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[59] Y. Najjar,et al. Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α , 2016, Clinical Cancer Research.
[60] S. H. van der Burg,et al. Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells. , 2016, Cancer research.
[61] K. Leandersson,et al. On the origin of myeloid-derived suppressor cells , 2016, Oncotarget.
[62] G. J. de Knegt,et al. Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis , 2016, American journal of respiratory cell and molecular biology.
[63] George A. Dominguez,et al. Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients , 2016, Science Immunology.
[64] A. Zhao,et al. CXCR2-Mediated Granulocytic Myeloid-Derived Suppressor Cells' Functional Characterization and Their Role in Maternal Fetal Interface. , 2016, DNA and cell biology.
[65] Peter J. Murray,et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards , 2016, Nature Communications.
[66] J. Moorman,et al. Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals , 2016, AIDS.
[67] M. Sade-Feldman,et al. Clinical Significance of Circulating CD33+CD11b+HLA-DR− Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab , 2016, Clinical Cancer Research.
[68] P. Sinha,et al. Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2 , 2016, The Journal of Immunology.
[69] S. H. van der Burg,et al. Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses , 2016, Science Translational Medicine.
[70] A. Peschel,et al. Myeloid-Derived Suppressor Cells in Bacterial Infections , 2016, Front. Cell. Infect. Microbiol..
[71] S. Groshen,et al. Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent. , 2016, Thyroid : official journal of the American Thyroid Association.
[72] I. Melero,et al. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs) , 2016, Clinical Cancer Research.
[73] C. Greenhill. Thyroid cancer: Use of MDSC to assess malignancy , 2016, Nature Reviews Endocrinology.
[74] A. Krüger,et al. The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib , 2016, Cancer Immunology, Immunotherapy.
[75] S. H. van der Burg,et al. Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study , 2016, Cancer Immunology, Immunotherapy.
[76] H. Salamon,et al. Infection with Mycobacterium tuberculosis induces the Warburg effect in mouse lungs , 2015, Scientific Reports.
[77] C. Montesano,et al. In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3&zgr; expression through ELF-1 inhibition , 2015, AIDS.
[78] S. Biswas. Metabolic Reprogramming of Immune Cells in Cancer Progression. , 2015, Immunity.
[79] S. Ugel,et al. Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. , 2015, The Journal of clinical investigation.
[80] W. Zou,et al. Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies , 2015, Cancer Immunology Research.
[81] T. Ottenhoff,et al. Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination , 2015, Front. Immunol..
[82] A. Sacchi,et al. Granulocytic Myeloid Derived Suppressor Cells Expansion during Active Pulmonary Tuberculosis Is Associated with High Nitric Oxide Plasma Level , 2015, PloS one.
[83] M. Nagarkatti,et al. Δ9‐Tetrahydrocannabinol‐mediated epigenetic modifications elicit myeloid‐derived suppressor cell activation via STAT3/S100A8 , 2015, Journal of leukocyte biology.
[84] A. Beineke,et al. A Major Role for Myeloid-Derived Suppressor Cells and a Minor Role for Regulatory T Cells in Immunosuppression during Staphylococcus aureus Infection , 2015, The Journal of Immunology.
[85] David M. Woods,et al. Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function. , 2015, Molecular immunology.
[86] T. Daemen,et al. Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy , 2015, Oncoimmunology.
[87] P. Sinha,et al. Cross‐talk among myeloid‐derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors , 2014, Journal of leukocyte biology.
[88] Y. Najjar,et al. Accumulation of MDSC subsets in renal cell carcinoma correlates with grade and progression free survival, and is associated with intratumoral expression of IL-1β, IL-8 and CXCL5 , 2014, Journal of Immunotherapy for Cancer.
[89] Je-in Youn,et al. Loss of Rb1 by epigenetic modification regulates expansion of MDSC in cancer , 2014, Journal of Immunotherapy for Cancer.
[90] A. Wege,et al. Myeloid‐derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice , 2014, European journal of immunology.
[91] H. Mollenkopf,et al. Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis. , 2014, American journal of respiratory and critical care medicine.
[92] I. Lowy,et al. Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab , 2014, Journal of Immunotherapy for Cancer.
[93] K. Flanagan,et al. Targeting regulatory T cells to improve vaccine immunogenicity in early life , 2014, Front. Microbiol..
[94] S. Kaufmann,et al. Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas , 2014, Proceedings of the National Academy of Sciences.
[95] L. Sengeløv,et al. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer , 2014, Cancer Immunology, Immunotherapy.
[96] J. Berzofsky,et al. Vaccine-induced myeloid cell population dampens protective immunity to SIV. , 2014, The Journal of clinical investigation.
[97] V. Bronte,et al. Myeloid‐derived suppressor cell heterogeneity in human cancers , 2014, Annals of the New York Academy of Sciences.
[98] V. Sosunov,et al. Gr-1dimCD11b+ Immature Myeloid-Derived Suppressor Cells but Not Neutrophils Are Markers of Lethal Tuberculosis Infection in Mice , 2014, The Journal of Immunology.
[99] D. Conrad,et al. Myeloid‐derived suppressor cells enhance IgE‐mediated mast cell responses , 2014, Journal of leukocyte biology.
[100] R. Pili,et al. Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer , 2014, OncoTargets and therapy.
[101] S. Spector,et al. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. , 2014, The Journal of infectious diseases.
[102] D. Schadendorf,et al. Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells , 2013, Clinical Cancer Research.
[103] M. Selman,et al. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. , 2013, American journal of respiratory and critical care medicine.
[104] I. Orme,et al. Gr1intCD11b+ Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection , 2013, PloS one.
[105] P. V. van Helden,et al. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function. , 2013, American journal of respiratory and critical care medicine.
[106] J. Khan,et al. Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. , 2013, Blood.
[107] Jin Hee Kim,et al. Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms , 2013, The Journal of Immunology.
[108] Ge Ma,et al. Polarization and reprogramming of myeloid-derived suppressor cells. , 2013, Journal of molecular cell biology.
[109] H. Zhang,et al. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. , 2013, The Journal of clinical investigation.
[110] Jun Luo,et al. Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment. , 2013, Cancer research.
[111] M. Hogardt,et al. Flagellin Induces Myeloid-Derived Suppressor Cells: Implications for Pseudomonas aeruginosa Infection in Cystic Fibrosis Lung Disease , 2013, The Journal of Immunology.
[112] Y. Najjar,et al. Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer , 2013, Front. Oncol..
[113] David G. Russell,et al. Intracellular Mycobacterium tuberculosis Exploits Host-derived Fatty Acids to Limit Metabolic Stress* , 2013, The Journal of Biological Chemistry.
[114] Yulia Nefedova,et al. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer , 2012, Nature Immunology.
[115] Wilfrid Boireau,et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth , 2012, Nature Medicine.
[116] F. Hu,et al. Expansion of Monocytic Myeloid-Derived Suppressor Cells Dampens T Cell Function in HIV-1-Seropositive Individuals , 2012, Journal of Virology.
[117] R. Draenert,et al. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells , 2012, Retrovirology.
[118] Janet S. Lee,et al. STAT1-Regulated Lung MDSC-like Cells Produce IL-10 and Efferocytose Apoptotic Neutrophils With Relevance In Resolution of Bacterial Pneumonia , 2012, Mucosal Immunology.
[119] Russell G. Jones,et al. Polarizing macrophages through reprogramming of glucose metabolism. , 2012, Cell metabolism.
[120] M. Manns,et al. S100A9 a new marker for monocytic human myeloid‐derived suppressor cells , 2012, Immunology.
[121] A. Sher,et al. Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. , 2011, Immunity.
[122] J. Wolchok,et al. Monocytic CCR2+ Myeloid Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T Cell Infiltration Into the Tumor Microenvironment , 2011 .
[123] G. Srikrishna. S100A8 and S100A9: New Insights into Their Roles in Malignancy , 2011, Journal of Innate Immunity.
[124] P. De Baetselier,et al. Myeloid-Derived Suppressor Cells Infiltrate the Heart in Acute Trypanosoma cruzi Infection , 2011, The Journal of Immunology.
[125] B. Rini,et al. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy. , 2011, International immunopharmacology.
[126] F. Végran,et al. Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapies. , 2011, Current molecular medicine.
[127] R. Coffman,et al. Vaccine adjuvants: putting innate immunity to work. , 2010, Immunity.
[128] T. Padhya,et al. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment , 2010, The Journal of experimental medicine.
[129] E. Rosenberg,et al. Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines. , 2010, AIDS research and human retroviruses.
[130] A. Mantovani,et al. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.
[131] D. Gilvary,et al. A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers , 2010, Clinical Cancer Research.
[132] J. Vincent,et al. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. , 2010, Cancer research.
[133] J. Berzofsky,et al. Blockade of TGF‐β enhances tumor vaccine efficacy mediated by CD8+ T cells , 2010, International journal of cancer.
[134] Zhiguang Li,et al. A Myeloid Cell Population Induced by Freund Adjuvant Suppresses T-cell−mediated Antitumor Immunity , 2010, Journal of immunotherapy.
[135] K. Pienta,et al. CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. , 2010, Cytokine & growth factor reviews.
[136] M. Chignard,et al. Mycobacterium bovis Bacillus Calmette-Guérin Vaccination Mobilizes Innate Myeloid-Derived Suppressor Cells Restraining In Vivo T Cell Priming via IL-1R–Dependent Nitric Oxide Production , 2010, The Journal of Immunology.
[137] E. Traggiai,et al. Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF , 2009, European Journal of Immunology.
[138] J. Berzofsky,et al. Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody , 2009, Clinical Cancer Research.
[139] E. Righi,et al. HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection. , 2009, The Journal of infectious diseases.
[140] H. Freeze,et al. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. , 2009, Neoplasia.
[141] P. Sinha,et al. Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1 , 2009, The Journal of Immunology.
[142] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[143] P. Dahm,et al. Reversal of Myeloid Cell–Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma , 2008, Clinical Cancer Research.
[144] Michelle Collazo,et al. Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.
[145] D. Foell,et al. Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells1 , 2008, The Journal of Immunology.
[146] J. Berzofsky,et al. Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2. , 2008, Cancer research.
[147] P. De Baetselier,et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. , 2008, Blood.
[148] M. Fishman,et al. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. , 2007, Cancer research.
[149] J. Leips,et al. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. , 2007, Cancer research.
[150] S. Albelda,et al. Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response1 , 2007, The Journal of Immunology.
[151] D. Quiceno,et al. L-arginine availability regulates T-lymphocyte cell-cycle progression. , 2007, Blood.
[152] F. Liew,et al. Role of nitric oxide in the regulation of T cell functions , 2006, Annals of the rheumatic diseases.
[153] Ingo Fricke,et al. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. , 2006, Cancer research.
[154] J. Berzofsky,et al. A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance , 2005, The Journal of experimental medicine.
[155] L. Kaiser,et al. Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity , 2005, Clinical Cancer Research.
[156] P. Andersen,et al. The success and failure of BCG — implications for a novel tuberculosis vaccine , 2005, Nature Reviews Microbiology.
[157] J. Berzofsky,et al. Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance , 2003, The Journal of Experimental Medicine.
[158] Bin Yu,et al. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. , 2003, Cancer research.
[159] A. Billiau,et al. Modes of action of Freund’s adjuvants in experimental models of autoimmune diseases , 2001, Journal of leukocyte biology.
[160] Jay A. Berzofsky,et al. NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway , 2000, Nature Immunology.
[161] M. Young,et al. Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer , 1996, International journal of cancer.
[162] L. G. Wayne. Dormancy ofMycobacterium tuberculosis and latency of disease , 1994, European Journal of Clinical Microbiology and Infectious Diseases.
[163] M. Young,et al. Myelopoiesis‐associated suppressor‐cell activity in mice with lewis lung carcinoma tumors: Interferon‐γ plus tumor necrosis factor‐α synergistically reduce suppressor cell activity , 1990 .
[164] J. Bennett,et al. Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[165] R. Tesi. MDSC; the Most Important Cell You Have Never Heard Of. , 2019, Trends in pharmacological sciences.
[166] S. Ostrand-Rosenberg,et al. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment. , 2015, Advances in cancer research.
[167] M. Nishimura,et al. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy , 2008, Cancer Immunology, Immunotherapy.
[168] S. Ostrand-Rosenberg,et al. The terminology issue for myeloid-derived suppressor cells. , 2007, Cancer research.
[169] Bin Yu,et al. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.